Deutsche Bank
SGMO

Deutsche Bank’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Deutsche Bank’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-840
Closed -$13K – 5450
2015
Q1 		$13K Buy
840
+200
+31% +$3.1K ﹤0.01% 4759
2014
Q4 		$9K Hold
640
– – ﹤0.01% 5739
2014
Q3 		$6K Buy
+640
New +$8.36K ﹤0.01% 5509

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank's SGMO Position: Q2 2024 in Review

Deutsche Bank sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 62,549 shares — an estimated $41.9K sold.

Deutsche Bank first reported a position in SGMO in Q2 2013 and held it in 44 quarters. The position peaked at $15.7M in Q2 2019. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.

  • Deutsche Bank reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 62,549 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $41.9K.
  • Deutsche Bank first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 44 quarters.
  • Deutsche Bank's SANGAMO THERAPEUTICS INC position peaked at $15.7M in Q2 2019.
  • 129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.